Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia
Year: 2007
Type: article
Source: Pharmacopsychiatry
Authors: T. Marinis, P. Saleem, P. Glue, W. Arnoldussen, R. Teijeiro, A. Lex, M. Latif, R. Medori
Institution: Azienda Sanitaria Locale Salerno
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: long-acting injectable risperidone, schizophrenia, antipsychotic switching, long-acting injectable antipsychotics, oral antipsychotics, medication adherence, treatment satisfaction, hospitalization, treatment-emergent adverse events, weight gain, quality of life, PANSS, Global Assessment of Functioning
Open Access status: closed
OpenAlex ID: W1974688396
